We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$707M
AUM Growth
+$55.8M
Cap. Flow
+$12.3M
Cap. Flow %
1.74%
Top 10 Hldgs %
23.82%
Holding
231
New
24
Increased
128
Reduced
58
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 16.96%
2 Healthcare 14.55%
3 Financials 8.45%
4 Industrials 6.87%
5 Communication Services 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
76
Duke Energy
DUK
$96.3B
$1.78M 0.25%
16,995
+2,423
+17% +$246K
XLK icon
77
State Street Technology Select Sector SPDR ETF
XLK
$124B
$1.73M 0.24%
19,870
-2,050
-9% -$169K
EWY icon
78
iShares MSCI South Korea ETF
EWY
$27.2B
$1.72M 0.24%
+22,115
New +$1.75M
CYRX icon
79
CryoPort
CYRX
$750M
$1.71M 0.24%
28,869
+16
+0.1% +$1.11K
ICLR icon
80
Icon
ICLR
$12.9B
$1.68M 0.24%
5,425
+66
+1% +$18.5K
OPRX icon
81
OptimizeRx
OPRX
$132M
$1.63M 0.23%
26,224
+1,362
+5% +$103K
UCTT
82
Ultra Clean Holdings
UCTT
$4.1B
$1.62M 0.23%
28,202
+738
+3% +$38.4K
LSCC icon
83
Lattice Semiconductor
LSCC
$18.4B
$1.59M 0.23%
20,644
+99
+0.5% +$7.35K
OMCL icon
84
Omnicell
OMCL
$1.69B
$1.57M 0.22%
8,721
+75
+0.9% +$13K
MX icon
85
Magnachip Semiconductor
MX
$139M
$1.55M 0.22%
74,051
+5,301
+8% +$98K
IBM icon
86
IBM
IBM
$222B
$1.53M 0.22%
11,446
+756
+7% +$94.8K
HBIO icon
87
Harvard Bioscience
HBIO
$27.8M
$1.52M 0.22%
21,636
+395
+2% +$28.1K
ESGD icon
88
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$1.52M 0.22%
19,115
+401
+2% +$31.9K
TFC icon
89
Truist Financial
TFC
$64.3B
$1.5M 0.21%
25,630
+3,880
+18% +$237K
DHR icon
90
Danaher
DHR
$145B
$1.49M 0.21%
5,101
+103
+2% +$28.4K
EXP icon
91
Eagle Materials
EXP
$6.47B
$1.48M 0.21%
8,858
+77
+0.9% +$11.8K
ASHR icon
92
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
$1.47M 0.21%
+37,511
New +$1.46M
CTLP
93
DELISTED
Cantaloupe
CTLP
$1.43M 0.2%
160,618
+17,849
+13% +$178K
CVX icon
94
Chevron
CVX
$386B
$1.42M 0.2%
12,125
+4,588
+61% +$521K
VCTR icon
95
Victory Capital Holdings
VCTR
$7.15B
$1.42M 0.2%
38,808
-238
-0.6% -$8.65K
CLAR icon
96
Clarus
CLAR
$141M
$1.41M 0.2%
50,871
+6,084
+14% +$168K
INFU icon
97
InfuSystem Holdings
INFU
$244M
$1.33M 0.19%
78,161
+11,253
+17% +$179K
CHDN icon
98
Churchill Downs
CHDN
$6.17B
$1.33M 0.19%
11,044
+370
+3% +$43.9K
RIO icon
99
Rio Tinto
RIO
$165B
$1.33M 0.19%
19,861
+4,849
+32% +$314K
CNMD icon
100
CONMED
CNMD
$1.48B
$1.27M 0.18%
8,985
+116
+1% +$16.4K

Similar funds

Greenwood Capital Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Greenwood Capital Associates held 231 positions worth $707M, up 8.6% from $651M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Greenwood Capital Associates's Q4 2021 filing shows 24 new, 128 increased, 58 reduced and 16 closed positions. Its largest new stake was iShares MSCI Global Min Vol Factor ETF: 40,246 shares worth $4.36M. The largest sale was Vanguard FTSE Europe ETF, an estimated $7.23M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q4 2021 buy was iShares MSCI Global Min Vol Factor ETF: 40,246 shares worth $4.36M.
  • Greenwood Capital Associates added most to iShares Core MSCI Total International Stock ETF in Q4 2021, an estimated $4.12M increase.
  • Greenwood Capital Associates's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.22M.
  • Greenwood Capital Associates fully exited Vanguard FTSE Europe ETF in Q4 2021, selling an estimated $7.23M.
  • Greenwood Capital Associates's ten largest holdings make up 24% of its $707M portfolio in Q4 2021.
  • Greenwood Capital Associates opened 24 new positions and closed 16 in Q4 2021.
  • Greenwood Capital Associates's portfolio value rose 8.6% quarter-over-quarter to $707M.

Based on Greenwood Capital Associates's 13F filing for Q4 2021, filed 3 Feb 2022.